Subhi Saadeh

Let's Combinate - Drugs + Devices

Science EN ↓ 252 episodes

Hello Combi-Nation! Our industry fee complicated sometimes. Drugs, devices, clinical trials, submissions, sterilization validation, design control, risk management, market access reimbursement, the list goes on. My name is Subhi Saadeh. I've spent over a decade in medical device, pharma, and combination product development. My goal is mastery, so this podcast is to ask questions I have to people who may have the answers. Whether you're background is Pharma, Device or both, I invite you to listen and together we can simplify by Combinating!

Author

Subhi Saadeh

Category

Science

Podcast website

letscombinate.com

Latest episode

Jul 8, 2026

Where to listen?

Podcasts in the app Replaio Radio Coming soon

Podcasts are coming to the app soon. Install now and be the first to see a whole new take on podcasts

Get it on Google Play Install for free Android 5M+ downloads · 4.8 rating iOS soon

Episodes

002 - “Seeing David in the Stone: Predictive Quality Management” with Larry Mager 14.10.2021

Excited to drop episode 002- “Seeing David in the Stone: Predictive Quality Management” with Larry Mager from Mgmt-Ctrl. I hope you enjoy this episode! Apple Podcasts: https://tinyurl.com/7y9k5kj8 Spotify: https://tinyurl.com/3w5chwhf Larry and I discuss a lot in this episode, most notably what Predictive Quality Management is and how “Quality is Free”. Larry Mager is the author of the books “The...

001 - “Learning Never Exhausts the Mind” with Rick Doe 06.10.2021

I wanted the first episode to be very special so I invited someone who was instrumental in my development as an engineer and a person. I’d like to introduce you to Episode 001 - “Learning Never Exhausts the Mind” with Rick Doe! https://www.linkedin.com/in/rick-doe-aa312330

Listen to the Let's Combinate - Drugs + Devices podcast in Replaio

Radio and podcasts in one app - free, with no sign-up. Install today and do not miss the launch

Get it on Google Play

Replaio is not a podcast publisher; show names, artwork and audio belong to their authors and are distributed through public RSS feeds.